News from Tarrytown
Stay current with all the latest and breaking news about Tarrytown, compare headlines and perspectives between news sources on stories happening today. In total, 9 stories have been published about Tarrytown which Ground News has aggregated in the past 3 months.
Weather
18°C
Sunday13° | 21°C
Monday12° | 26°C
Tuesday14° | 29°C
Wednesday16° | 30°C
Thursday18° | 26°C
Friday13° | 28°C
Suggest a source
Looking for a source we don't already have? Suggest one here.Top Tarrytown News
Latest News Stories
Tarrytown · TarrytownTARRYTOWN, N.Y., April 03, 2024 (GLOBE NEWSWIRE) -- 1949 was a big year for barf, welcoming the invention of the barf bag and Dramamine®. Seventy-five years later, Dramamine, a Prestige Consumer Healthcare brand, thrives as the number one brand for motion sickness relief, but as Dramamine has risen in popularity, the use of barf bags has sadly diminished. To commemorate the joint anniversary, Dramamine® is breathing new life – not barf – into …See the Story
Dramamine® Celebrates its 75th Anniversary by Reviving an Unexpected Partner: The Barf Bag - Prestige Consumer (NYSE:PBH)
100% Center coverage: 1 sources
Tarrytown · TarrytownChef Dale's one-night-only pop-up at Ramen-san is sold out. There will be future collaborations at Ramensan this Spring/Summer. Recipe: Shanghai Lumpia Recipe Courtesy of Dale Talde,Goosefeather (Tarrytown, NY) Black Truffle Soy MOP: Steep together soy sauce and reserved truffle peeling liquid.See the Story
Lunchbreak: Shanghai Lumpia
100% Center coverage: 1 sources
Tarrytown · TarrytownPublished results show EYLEA HD with extended 12- or 16-week dosing regimens demonstrated non-inferior vision gains to standard of care EYLEA® (aflibercept) Injection 2 mg with fixed 8-week dosing in patients with wAMD and DME in the first year EYLEA HD has shown impressive durable visual improvements and rapid and resilient fluid control with a safety profile comparable to EYLEA Extended dosing intervals with EYLEA HD have the potential to subs…See the Story
EYLEA® HD (aflibercept) Injection 8 mg Pivotal Data in Wet Age-related Macular Degeneration (wAMD) and Diabetic Macular Edema (DME) Published in The Lancet - Regeneron Pharmaceuticals (NASDAQ:REGN)
100% Center coverage: 1 sources
Tarrytown · TarrytownNEW YORK (PIX11) -- This will be the sixth time handmade chocolate-covered pretzels from Posh Pretzels in Tarrytown will be featured in Oscar swag bags for the top category nominees as well as for the show’s host. “It’s the ultimate accolade, quite honestly. It’s not that easy to get into, and they welcome me every time, and it’s confirmation that I’m doing something right!" owner Annmarie D'Erasmo said. With so many flavors to choose from, D’E…See the Story
Local NYC pretzel shop makes Oscar swag bags
100% Center coverage: 1 sources
Tarrytown · TarrytownDupixent is the leading biologic treatment for all five of its FDA-approved indications in new-to-brand prescriptions in the U.S. Priority Review granted based on positive results from two Phase 3 trials. If approved, Dupixent would be the only biologic therapy for COPD and the first new treatment approach for this disease in more than a decade.See the Story
Dupixent® (dupilumab) sBLA Accepted for FDA Priority Review for Treatment of COPD with Type 2 Inflammation - Regeneron Pharmaceuticals (NASDAQ:REGN)
100% Center coverage: 1 sources
Tarrytown · TarrytownTARRYTOWN, N.Y., Feb. 21, 2024 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) today announced that the U.S. Food and Drug Administration (FDA) has accepted for Priority Review the Biologics License Application (BLA) for linvoseltamab to treat adult patients with relapsed/refractory (R/R) multiple myeloma (MM) that has progressed after at least three prior therapies. The target action date for the FDA decision is August 22, 2…See the Story
Linvoseltamab BLA for Treatment of Relapsed/Refractory Multiple Myeloma Accepted for FDA Priority Review - Regeneron Pharmaceuticals (NASDAQ:REGN)
100% Center coverage: 1 sources